Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
| Issue Open | February 26, 2024 |
| Issue Close | March 20, 2024 |
| Issue Size (Shares) | 1.30 Crores |
| Issue Size (Amount) | ₹12.97 Crores |
| Issue Price | ₹10 per Share |
| Listing At | BSE |
Dipna Pharmachem Ltd. is coming up with Right Issue of the face value of ₹ 10 each, for an amount of ₹1.30 Crores ('Base Issue Size') with an option to retain oversubscription up to ₹12.97 Crores.
Incorporated in 2011, Dipna Pharmachem Limited (DPL) is an India-based company that trades, imports, and exports industrial chemical and pharmaceutical raw materials.These include active pharmaceutical ingredients (APIs), excipients, and chemical formulation products.
The issue opens on Feb 26, 2024 and closes for subscription on Mar 20, 2024. The shares of the company to be list at BSE.
The public issue of Dipna Pharmachem Ltd. opens on Feb 26, 2024 and closes for subscription on Mar 20, 2024.
The Dipna Pharmachem Rights Issue 2024 are proposed to list at BSE.
This page provides Rights Issue news of Dipna Pharmachem Rights Issue 2024. The Dipna Pharmachem Rights Issue 2024 watch offers the latest Rights Issue issue news and keep you updated with the latest Rights Issue news in India.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
